Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FR.1.3ORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-22329.9Japan
B.1.1.316ORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-22347Japan
B.1.480ORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-22347Japan
XLORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-22347Japan
BA.2.31ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-22371Japan
AY.4.5 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
C.36.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
B.1.1.193NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
B.1.525 (Eta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
EG.5.2.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
B.1.243NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
AY.99.1 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
AY.121 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
KR.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
B.1.243.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
B.1.1.377NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
B.1.279NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
B.1.1.513NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.338NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.284NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.9.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.498NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.184NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.187NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
D.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AE.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.110.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.342NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.500NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.511NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.428.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.506NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.482NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.335NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.36NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.499.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.116NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.134NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.393NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.381NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AE.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.516NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.526NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.279NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AE.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
N.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.36NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.407NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used